How big is the therapeutic device contract manufacturing market?

In 2027, the market for therapeutic device contract manufacturing is worth approximately USD 74.32 billion.

What is the anticipated CAGR of the therapeutic device contract manufacturing industry?

Therapeutic Device Contract Manufacturing Market size stood at USD 66.43 billion in 2026 and is predicted to grow at a 13.73% CAGR from 2027 to 2036, reaching USD 240.5 billion by 2036.

How is outsourcing changing manufacturing strategies for therapeutic device companies?

Medical companies are increasingly outsourcing production to access specialized capabilities, engineering expertise, and scalable infrastructure while concentrating internal resources on product development and commercialization.

Why are regulatory requirements increasing reliance on specialized contract manufacturers?

Stringent requirements for safety, validation, traceability, and quality management favor contract manufacturers with established compliance processes, helping device companies maintain consistent production and documentation across the product lifecycle.

Why does Class II dominate the therapeutic device contract manufacturing market?

Class II accounts for 79.63% of the market in 2026, reflecting demand for devices requiring specialized manufacturing, rigorous quality assurance, and regulatory compliance. Outsourcing helps developers access technical expertise and scale production efficiently.

How are OEMs strengthening demand for therapeutic device contract manufacturing?

OEMs are the largest and fastest-growing end-use segment, using contract manufacturers to access specialized production capabilities, manage costs, and scale manufacturing. These partnerships also support product commercialization, quality consistency, and flexible production planning.

Why does Asia Pacific dominate therapeutic device contract manufacturing?

Asia Pacific held 40.93% of the market in 2026, supported by cost-efficient production, expanding medical device manufacturing capabilities, and growing demand for outsourced manufacturing services.

How is Asia Pacific strengthening its position in therapeutic device contract manufacturing?

Investment in advanced manufacturing technologies, quality systems, and specialized production capabilities is improving regional competitiveness as medical device companies increasingly outsource manufacturing operations.

Which companies are driving growth in the therapeutic device contract manufacturing landscape?

Key players in the therapeutic device contract manufacturing market include Thermo Fisher Scientific (USA), Integer Holdings (USA), FLEX LTD (USA/Singapore), Celestica (Canada), Phillips-Medisize (USA), Plexus Corp. (USA), Nipro Corp. (Japan), Viant Technology (USA), West Pharmaceutical Services (USA), Synecco (UK).